Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major Depression

1988 ◽  
Vol 8 (2) ◽  
pp. 112???115 ◽  
Author(s):  
WILLIAM F. BYERLEY ◽  
FRED W. REIMHERR ◽  
DAVID R. WOOD ◽  
BERNARD I. GROSSER
1988 ◽  
Vol 94 (1) ◽  
pp. 141-143 ◽  
Author(s):  
William F. Byerley ◽  
Elizabeth J. McConnell ◽  
R. Tyler McCabe ◽  
Ted M. Dawson ◽  
Bernard I. Grosser ◽  
...  

1981 ◽  
Vol 70 (2) ◽  
pp. 195-202 ◽  
Author(s):  
W.Jan Vaatstra ◽  
Wilhelmina M.A. Deiman-Van Aalst ◽  
Leo Eigeman

1987 ◽  
Vol 151 (3) ◽  
pp. 337-340 ◽  
Author(s):  
J. P. R. Young ◽  
A. Coleman ◽  
M. H. Lader

Fluoxetine, a selective serotonin uptake inhibitor (mean dose 73 mg each morning) was compared with amitriptyline (mean dose 122 mg at night) in a double-blind study of 64 depressed out-patients. Fifty patients completed the 6-week trial. The drugs did not differ with respect to psychiatrists' ratings, but amitriptyline was slightly superior with respect to patients' ratings. The amitriptyline-treated group had complaints of dry mouth and dizziness on standing; the fluoxetine-treated group of sleep disturbances, nausea, and headaches.


Sign in / Sign up

Export Citation Format

Share Document